Double or triple down: how AFT Pharmaceuticals plans to win in China

Double or triple down: how AFT Pharmaceuticals plans to win in China
(Image: Getty)
Rebecca Stevenson
AFT Pharmaceuticals says it has increased manufacturing capacity and brought in market experts as it prepares to launch its antibacterial cream in China. The New Zealand Exchange-listed (NZX) firm reported its results for the 12 months to March 31 on May 23. Its international and Asian sales rose 70%, accounting for 20% of revenue. Operating revenue for AFT’s Asian business grew 57% to $10.7 million from $6.8m, while operating profit rose to $2.5m from $900,000.It said growth was driven through the hospital channel, wi...

More Markets

Vector agrees to sell LPG assets for $150m
Markets

Vector agrees to sell LPG assets for $150m

The deal is subject to regulatory approvals and commercial conditions.

Rebecca Howard 26 Jul 2024
ASX: Australian shares slide to a two-week low as tech drags
Markets

ASX: Australian shares slide to a two-week low as tech drags

Every sector of the Australian share market has lost ground.

AAP 26 Jul 2024
NZ sharemarket down 0.38%
Markets Market close

NZ sharemarket down 0.38%

The S&P/NZX 50 Index closed at the day’s low of 12,349.47, down 46.79 points or 0.38%.

Graham Skellern 26 Jul 2024
Forsyth Barr initiates full Turners coverage
Markets

Forsyth Barr initiates full Turners coverage

Forsyth Barr says a premium valuation is now warranted. 

Rebecca Howard 26 Jul 2024